Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain

By Pascual Maria Luz G.   Fleming Rosa Rosanna B.   Gana Theophilus J.   Vorsanger Gary J.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2531-2542

Informa Healthcare

Access to resources Recommend Favorite

Extended‐release mixed amphetamine salts effective for comorbid ADHD, cocaine use

By  

THE BROWN UNIVERSITY PSYCHOPHARMACOLOGY UPDATE, Vol. 26, Iss. 8, 2015-08 ,pp. : 1-7

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioavailability of triple-bead mixed amphetamine salts compared with a dose-augmentation strategy of mixed amphetamine salts extended release plus mixed amphetamine salts immediate release

By Ermer James C.   Shojaei Amir   Pennick Michael   Anderson Colleen S.   Silverberg Arthur   Youcha Sharon H.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1067-1075

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 471-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability

By Montgomery Stuart   Emir Birol   Haswell Hannah   Prieto Rita  

Current Medical Research and Opinion, Vol. 29, Iss. 10, 2013-10 ,pp. : 1223-1230

Informa Healthcare

Access to resources Recommend Favorite